Understanding the Drug of Choice for Mycobacterium tuberculosis Treatment
•
4 min read
Globally, millions of people fall ill with tuberculosis (TB) each year, making it a persistent public health threat. For active disease caused by drug-susceptible *Mycobacterium tuberculosis*, there is no single "drug of choice" but rather a carefully structured, multi-phase regimen using a combination of first-line medications. This approach is crucial to ensure efficacy, minimize treatment duration, and prevent the emergence of drug resistance.
